| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $98.4M | +63.5% |
| SG&A Expense | $29.0M | +24.2% |
| Operating Income | -$127.4M | -52.5% |
| Pre-tax Income | -$123.4M | -47.8% |
| Income Tax | $64K | +404.8% |
| Net Income | -$123.5M | -47.9% |
| EPS (Basic) | -$3.03 | -46.4% |
| EPS (Diluted) | -$3.03 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.8M | -86.6% |
| Short-term Investments | $217.4M | — |
| Current Assets | $271.0M | -26.2% |
| Total Assets | $306.5M | -19.4% |
| Current Liabilities | $28.3M | +85.2% |
| Long-term Debt | $10.6M | — |
| Total Liabilities | $43.0M | +151.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.2M | -31.0% |
| Capital Expenditures | $1.4M | +114.3% |
| Investing Cash Flow | -$235.4M | -4682.0% |
| Financing Cash Flow | $9.9M | +298.9% |
| Free Cash Flow | -$90.7M | -31.8% |
| -46.4% |
| Stockholders' Equity |
| $263.5M |
| -27.4% |